Yale University lab has crafted the first ever synthetic molecules that have both the targeting and response functions of antibodies.
The new molecules -- synthetic antibody mimics (SyAMs) -- attach themselves simultaneously to disease cells and disease-fighting cells. The result is a highly targeted immune response, similar to the action of natural human antibodies.
Scientists Develop Protective Antibodies Against the Deadly Hantavirus
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have used a novel approach to develop protective antibodies against the potentially deadly hantavirus.
Advertisement
"Unlike antibodies, however, our molecules are synthetic organic compounds that are approximately one-twentieth the size of antibodies," said David A. Spiegel, a professor of chemistry at Yale whose lab developed the molecules. "They are unlikely to cause unwanted immune reactions due to their structure, are thermally stable, and have the potential to be administered orally, just like traditional, small-molecule drugs."
Spiegel and his team describe the research in a paper published online Dec. 16 by the Journal of the American Chemical Society.
The paper looks specifically at SyAM molecules used to attack prostate cancer. Called SyAM-Ps, they work first by recognizing cancer cells and binding with a specific protein on their surface. Next, they also bind with a receptor on an immune cell. This induces a targeted response that leads to the destruction of the cancer cell.
![Antibodies Turned into Highly Tuned]( "Antibodies Turned into Highly Tuned")
Extensive research has shown that antibodies are among the most useful tools in biology and medicine.
Spiegel said the process of synthesizing and optimizing the structure of the molecules required considerable time and effort. "We now know that synthetic molecules of intermediate size possess perhaps the most important functional properties of antibodies -- targeting and stimulation of immune cells," he said.
"It's also noteworthy that molecules of such a small size can bring together two objects as enormous as cells, and trigger a specific functional response, entirely as a result of specific receptor interactions," Spiegel added.
Beyond their potential for treating prostate cancer, SyAMs may have applications for treating other forms of cancer, HIV and various bacterial diseases.
Spiegel also is a member of Yale Cancer Center.
Source: Eurekalert
The paper looks specifically at SyAM molecules used to attack prostate cancer. Called SyAM-Ps, they work first by recognizing cancer cells and binding with a specific protein on their surface. Next, they also bind with a receptor on an immune cell. This induces a targeted response that leads to the destruction of the cancer cell.
Antibodies Turned into Highly Tuned 'Nanobodies' Via New Technique
Extensive research has shown that antibodies are among the most useful tools in biology and medicine.
Advertisement
Spiegel said the process of synthesizing and optimizing the structure of the molecules required considerable time and effort. "We now know that synthetic molecules of intermediate size possess perhaps the most important functional properties of antibodies -- targeting and stimulation of immune cells," he said.
"It's also noteworthy that molecules of such a small size can bring together two objects as enormous as cells, and trigger a specific functional response, entirely as a result of specific receptor interactions," Spiegel added.
Beyond their potential for treating prostate cancer, SyAMs may have applications for treating other forms of cancer, HIV and various bacterial diseases.
Spiegel also is a member of Yale Cancer Center.
Source: Eurekalert
Mice Study: Genetic 'Instruction Set' for Antibodies Knocks Down Hepatitis C
A study has revealed that a triple-punch of antibodies was able to prevent hepatitis C infection in laboratory mice.
Advertisement
 Stem Cells can be Directed Towards Injured Organs by Combining Antibodies, Iron Nanoparticles and MagnetsAntibody-studded iron nanoparticles were infused into the bloodstream to treat heart attack damage by researchers at the Cedars-Sinai Heart Institute. | Advertisement
|
Advertisement
Latest Research News
Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.